Tizanidine Tablet
Product Images NDC 72789-327

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 72789-327). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image (72789327)

Image (72789327)
Tizanidine tablets are a medication that may cause drowsiness, and it is advised to use caution while driving or performing tasks requiring mental alertness. These tablets are not interchangeable with Tizanidine capsules. Each tablet contains 4.576 mg Tizanidine HCL USP equivalent to 4 mg of Tizanidine base, and the dosage and storage information can be found on the package insert. The tablets are marked with "AN" and "tiZANidine USP 4MG" and come in a bottle containing 20 tablets. They should be kept out of reach of children, and side effects should be reported to a medical professional. The expiration date of the tablets is 10/2025, and the lot number is 623899.*
FDA Label Image

Tizanidine-1 (Tizanidine 1)

Tizanidine-1 (Tizanidine 1)
FDA Label Image

Tizanidine-2 (Tizanidine 2)

Tizanidine-2 (Tizanidine 2)
FDA Label Image

Tizanidine-3 (Tizanidine 3)

Tizanidine-3 (Tizanidine 3)
FDA Label Image

Tizanidine-4 (Tizanidine 4)

Tizanidine-4 (Tizanidine 4)
This text describes the improvement in Ashworth score with a mean dose of 26.8 mg in a study that lasts for 7 weeks. The endpoint is determined using the last observation carried forward method.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.